1 – 5 of 10
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Targeting miRNA by CRISPR/Cas in cancer : advantages and challenges
(
- Contribution to journal › Scientific review
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
(
- Contribution to journal › Article
- 2022
-
Mark
Testicular Dysfunction Among Cancer Survivors
(
- Contribution to journal › Scientific review
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
(
- Contribution to journal › Article